Skip to main content
Premium Trial:

Request an Annual Quote

Aclara and USC s Cancer Center in Research Collaboration

NEW YORK, April 16 -- Aclara BioSciences and the Norris Comprehensive Cancer Center and Hospital of the University of Southern California today announced a research agreement targeting cancer biomarkers.

 

The research project will employ Aclara's eTag assay to seek biomarkers for breast cancer, developing assays for receptor-complexes and phophorylation events to profile epidermal growth factor receptor family signal transduction pathways, Aclara of Mountain View, Calif., said in a statement.

 

Financial details were not provided.

 

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.